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Abstract 
The Born in Guangzhou Cohort Study (BIGCS) is a large-scale prospective observational study investigating the 
role of social, biological and environmental influences on pregnancy and child health and development in an 
urban setting in southern China. Pregnant women who reside in Guangzhou and who attend Guangzhou Women 
and Children’s Medical Center (GWCMC) for antenatal care in early pregnancy (less than 20 weeks’ gestation) 
are eligible for inclusion. Study recruitment commenced in February 2012, with an overall participation rate of 
76.3%. Study recruitment will continue until December 2018 to achieve the target sample size of 30 000 
mother-child pairs. At 30 April 2016, a total of 75 422 questionnaires have been collected, while 14 696 live 
births have occurred with planned follow-up of cohort children until age 18 years. During the same period a total 
of 1 053 000 biological samples have been collected from participants, including maternal, paternal and infant 
blood, cord blood, placenta, umbilical cord, and maternal and infant stool samples. The dataset has been 
enhanced by record linkage to routine health and administrative records. We plan future record linkage to school 
enrolment and national examination records.  
Keywords 
Design; Cohort study; Child; Pregnancy; Record linkage  
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Introduction 
Since initiating economic reform and opening-up trading policy in 1978, China has experienced an 
unprecedented period of economic and social development. Significant progress in healthcare delivery and 
utilization are reflected in improved human development indicators, best illustrated by the reduction in child 
mortality from 46.0 to 13.7 per 1000 live births (1996 - 2012) [1] and decline in maternal mortality from 141.7 
to 20.1 per 100 000 (1996 - 2015) [2, 3]. Meanwhile, rapid economic ascendance has presented new health and 
social challenges, including an increasing burden of non-communicable diseases.  
The Born in Guangzhou Cohort Study (BIGCS) is a large-scale prospective study of mothers and their 
children from the prenatal period to adult life in the urban setting of Guangzhou, China. Guangzhou is located on 
the Pearl River Delta in southern China (Figure 1), one of the first ports in China to initiate global trading, 
rapidly developing into a cosmopolitan city. The population has nearly tripled in the past 30 years, from 4.8 
million in 1978 to 13.1 million in 2014, meanwhile during the same period the Per Capita Gross Domestic 
Product increased from < 1000 yuan to 128 000 yuan [4]. Undoubtedly, economic and social developments have 
had a profound impact on the health of the resident population. The contemporary generation of women of 
childbearing age in Guangzhou has experienced this phase of rapid economic development and social transition, 
including the now abolished one child family planning policy. Given these circumstances, a birth cohort of the 
contemporary generation of mothers and their children provides a unique opportunity to investigate the short- 
and long-term health consequences from a life course perspective. Compared to other contemporary birth cohorts 
in mainland China [5, 6], BIGCS has a larger sample size and more comprehensive collection of biological 
samples with the potential to assess internal exposure and address key research questions in maternal and child 
health. Most importantly, we anticipate the rapid economic development and social transition occurring in 
Guangzhou is likely to be replicated in other places China in the future. Thus BIGCS will provide information to 
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inform researchers, policy makers and other stakeholders in these areas. 
In the context of this unique setting and period of historical importance, the objectives of BIGCS is to 
investigate the influence of social, genetic and environmental factors on a range of maternal, child and 
adolescent health outcomes to inform and improve the lives of future generations of children and their families, 
and to provide a basis for intervention strategies, of direct relevance to other cities in China and similar 
economic transition settings worldwide. Five major research themes will be explored: maternal health and 
pregnancy outcomes, fetal growth and development, immunological development in early life, 
neurodevelopmental pathways and parental risk factors for infant and child health outcomes.  
Funding for BIGCS was provided by the Guangzhou Women and Children’s Medical Center (GWCMC), 
the Guangzhou Science Technology and Innovation Commission, and Health and Family Planning Commission 
of Guangzhou Municipality.  
 
Study cohort 
The BIGCS recruits women during early pregnancy at two campuses of the GWCMC. This maternity center is 
one of the largest tertiary hospitals in China, with 18 000-20 000 annual deliveries of 220 000 total births in the 
Guangzhou municipality. In the antenatal outpatient clinic setting trained study personnel invite participation of 
pregnant women attending for early pregnancy examination. Eligible women are those of Chinese nationality, 
living in Guangzhou who are at less than 20 weeks of gestation and who intend to deliver at one of the two 
GWCMC campuses. Further criteria include ability to complete questionnaires in Mandarin or Cantonese 
language and an intention to remain in Guangzhou for at least three years after delivery. Partners of the eligible 
women are also invited to participate. Informed, written consent is obtained from all study participants and may 
be withdrawn at any stage of the study.  
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A three-month pilot study was conducted to evaluate the effectiveness of recruitment and follow-up 
methods, prior to the commencement of full-scale study recruitment in February 2012. The overall cohort sample 
size target is 30 000 mother-child pairs, which provides adequate power to detect moderately strong causal 
effects of common environmental, social and biological exposures. (Supplementary table 1)  
By April 2016, we had approached 22 569 eligible pregnancies, of which 17 214 (from 17 050 women) 
provided consent (participation rate 76.3 %). Table 1 shows baseline characteristics among women who agreed 
and disagreed to participate in the study, with women of higher educational status being more likely to 
participate, although mean age was similar in both groups. Of those partners present at initial recruitment 
(n=7131, 41.4%) in early pregnancy, overall 4080 (57.2%) participated in the study.  
 
Follow up 
Maternal and paternal information, clinical measures and biological samples are collected at recruitment, 24-27 
and 35-38 weeks of gestation. After delivery, maternal information including employment status, anthropometric 
measures and physical and mental health- related information would be followed up.  
For cohort children, neonatal birth information including mode of delivery, birth characteristics (e.g. birth 
weight, birth length) and perinatal outcomes are obtained from routine medical records. Mothers are interviewed 
and children are examined in GWCMC’s child health care clinics at age 6 weeks, 6, 12 and 36 months, or by 
telephone interview for those mothers who are unable to bring their child to the pediatric clinic. We plan to 
follow-up all cohort children until age 18 years.   
Figure 2 shows study participant recruitment and follow-up until 30 April, 2016. At this stage of recruitment, 
a total of 1090 women (6.3%) had withdrawn consent for participation, with the following reasons (obtained by 
multiple choice item): (i) family disapproval (10.7%), (ii) reluctance to complete time-consuming questionnaire 
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(50.9%), (iii) unwilling to provide a blood sample (10.7%), (iv) selection of an alternative hospital for antenatal 
examination or delivery (14.4%), (v) moved out of Guangzhou (8.9%), and (vi) other reason (9.3%).  
Table 2 presents the socio-demographic characteristics of those women who have withdrawn consent for 
study participation. Compared to those who continue in the study, women who opted out of the study were more 
likely to have lower levels of education, income and pre-pregnancy body mass index (BMI) and to be 
multiparous.  
 
Data collection 
For participating mothers, a summary of measures (questionnaire, clinical assessment, anthropometry and 
biological samples) collected at each follow-up phase are presented in Table 3. Semi-structured questionnaires 
are used to collect maternal data, including validated measures for socioeconomic status, occupational exposure, 
physical activity, dietary habits and mental health. Maternal dietary habits were evaluated using a validated food 
frequency questionnaire [7]. Mental health (depression and anxiety) during pregnancy was assessed by a 20-item 
self-rating depression scale (SDS) and a 20-item self-rating anxiety scale (SAS) [8, 9], and the postpartum 
depression was evaluated using the Chinese version of the Edinburgh Postnatal Depression Scale (EPDS) [10]. 
Clinical information during pregnancy including antenatal screening test results, ultrasound findings, obstetric 
complications and prescribed medication are obtained through medical records. At all contact points post-partum, 
we collect information on anthropometry, medical conditions and mental health.  
For participating fathers, socio-demographic, family and personal medical history are recorded by the 
baseline questionnaire at recruitment, and blood samples (7 mL) are collected at the time of questionnaire 
completion (Table 3). 
For participating children, data on newborn birth characteristics is obtained from delivery records. Cord 
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blood, umbilical cord, placenta were collected at birth. Heel prick dried blood spots (3 spots, each has a diameter 
of >8 mm) are collected within 48 hours after birth. Stool samples are collected at birth and at 6 weeks of age. In 
early childhood, we take advantage of the routine state health checks at 6 weeks, 6, 12 and 36 months of age, 
provided free of charge for children living in Guangzhou. Each check comprises a blood test, clinical assessment, 
physical measurements (weight, body length/ height, head/ chest/ abdomen/ upper arm circumference, skinfold 
thickness, bregmatic fontanel), clinical examination (dental eruption and breast/ testis volume) and 
neurobehavioral assessment using standardized tools (Chinese versions of Ages and Stages Questionnaire- III, 
ASQ-III and Gesell Development Scale, GDS), all of which are performed by trained members of the research 
team. The instruments of ASQ-III and GDS have been validated in Chinese population [11, 12]. The follow-up 
schedule of the preterm birth infants is chronologically the same as the full-term infants. Further clinical 
information including clinical test results, medication history and disease diagnosis are collected through record 
linkage to children’s medical information. Data on immunization history and physical measurements of children 
before age 6 years are similarly extracted from community health records. In addition, during the pre-school 
period, blood samples (4 mL) will be collected at age 1 and 3 years (Table 4). We plan to obtain routine health 
and academic performance information after age 6 years by record linkage to the databases of the Guangzhou 
Bureau of Education. 
 
Key findings and publications  
The median maternal age at recruitment was 29.2 years. Of those participating in the study, 83.5% of mothers 
were primiparous, 65.3% had an educational level of undergraduate and above, 42.7% were in employment with 
modal category of maternal income 4501-9000 yuan per month, which is higher than the average level of per 
capita monthly income in China (4134 yuan in 2015) [13]. The mean total gestational weight gain was 14.98 kg 
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among 6085 primiparous women who delivered a term (≥ 37 weeks gestation) singleton baby. Within the same 
period (February 2012 to April 2016), there were 14 696 deliveries, resulting in 14 142 singleton and 332 
multiple births. Among the 14 142 singleton births, 730 (5.2%) were preterm birth (PTB).  
Using data on 9 044 singleton live births whose mothers were recruited between February 2012 and 
December 2014, we found maternal age (OR: 1.06, 95% CI: 1.03-1.09 for each year increase), history of 
preterm delivery (OR: 3.22, 95% CI: 1.55-6.67 for multiparous women with previous preterm delivery), vaginal 
bleeding during pregnancy (OR: 1.71, 95% CI: 1.39-2.10) and folic acid intake before pregnancy (OR: 0.77, 95% 
CI: 0.62-0.95) were associated with the risk of PTB (manuscript submitted). 
Gestational diabetes mellitus (GDM) is one of the most prevalent major complications during pregnancy. 
Based on the findings from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study [14], the 
International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommended a new set of 
criteria for diagnosing GDM in 2010 [15], resulting in higher diagnosed rates of GDM. For example, in China 
the prevalence has risen markedly from 5.0% in 2006 to 22.7% in 2011; while in BIGCS it is diagnosed in 14.2% 
of the mothers. We assessed the risk of LGA according to the different GDM diagnostic criteria among 6 993 
participants who underwent a 2-h 75 g oral glucose tolerance test (OGTT) between 22 and 28 weeks gestational 
age. We found that a single measurement of fasting plasma glucose level can identify women at increased risk of 
delivering a LGA baby. The addition of 1-h and/or 2-h plasma glucose levels has only very limited additional 
value [16]. 
As a modifiable factor, maternal dietary habits may contribute to the development of GDM [17]. Using 
dietary information collected by the mid-pregnancy 64-item food-frequency questionnaire from 3063 mothers, 
we characterized four predominant dietary patterns during pregnancy (vegetable, protein-rich, prudent, and 
sweets and seafood patterns), and observed an increased risk of GDM associated with high intake of sweets and 
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seafood (OR: 1.23; 95% CI: 1.02, 1.49) and reduced risk among those had high intake of vegetables (OR: 0.79; 
95% CI: 0.64, 0.97) [18].  
We have also examined the association between maternal progesterone supplementation during early 
pregnancy (<14 weeks) and adverse birth outcomes in 6617 pregnant women. Our findings suggest that 
progesterone use in early pregnancy may offer limited benefit and could increase the risk of adverse birth 
outcomes. Due to the high prevalence of progesterone use in China, this could potentially have important public 
health significance [19]. 
We are also interested in the maternal mental health. We found evidence linking maternal exposure to 
passive smoking and depression during pregnancy. Among 6 247 pregnant women, high exposure to passive 
smoking (≥30 minutes/day) during early and late pregnancy both increased the risk of maternal depression 
during late pregnancy (RR: 1.49, 95% CI: 1.17-1.91 and RR: 1.45, 95%CI: 1.07-1.97, respectively) compared to 
those who were not exposed (< 1 minute/day). We also found an association between passive smoking during 
pregnancy and postpartum depression (RR: 1.60, 95%CI: 1.15, 2.22) [20]. This may be mediated by systemic 
inflammation, as demonstrated by an association between plasma c-reactive protein (a biomarker for 
inflammation) levels in late pregnancy and incidence of postpartum depression (OR: 1.13; 95% CI: 1.02, 1.26 
per unit increase) in a subsample of 513 pregnant women from BIGCS [21]. 
 
Main strengths and weaknesses 
This cohort has a number of strengths. (i) The large specific population in the BIGCS has undergone a unique 
and exceptionally rapid period of social, economic and epidemiological transition. (ii) We have collected detailed 
comprehensive information using a range of techniques, including clinical information (medical record linkage, 
measurements of medical examinations), self-report and multiple sequential biological samples. The 
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comprehensive biobank we have constructed is used to store a wide range of biological specimens at a central 
on-site facility, with standardised procedures for sample handling, processing and analysis to ensure high levels 
of validity and reproducibility. Also, the collection of stool samples enables us to investigate the effects of 
microbiota on maternal and child health. (iii) We are actively engaging with technical advances and rapid 
development of emerging new technologies, including metabolomics, metagenomics, immunomics, and 
proteomics. Such applications have the potential to provide insight into short- and long-term consequences of 
those fetal and early life macro and micro-environmental exposures which accompany social transition and 
economic development [22].  
Several challenges of this ambitious cohort study should be considered. Social development in Guangzhou 
is at a much more advanced stage compared with many parts of China, particularly the more rural provinces in 
the west. It is not the intention of this study to recruit a nationally representative sample of pregnant women 
across China. In fact, our sample is not representative of the Guangzhou population because of mothers receiving 
antenatal care at the GWCMC are likely to be more affluent and older and have higher education than the 
contemporary pregnant women in Guangzhou, hence limiting generalizability of our findings. This selection bias 
had been recognized and acknowledged from an early design stage of our study. Nevertheless, even within our 
participants we were able to observe a relatively wide spread across all social-economic status (SES) indicators, 
hence enabling us to explore the differences in health consequences across different SES strata. Furthermore, the 
aim of the study is to examine and identify potential associations between exposure and key maternal and child 
health outcomes, and such estimates provide validity even when assessed within a non-representative sample of 
the overall study population. The collection of questionnaire information or biological samples during the 
preconception period remains a challenge as experienced within the majority of large-scale birth cohort studies. 
Although not possible for the entire cohort, we are planning a preconception recruitment of a subset of women 
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during the second recruitment phase.  
 
Data available 
The Born in Guangzhou Cohort Study welcomes collaboration and we are keen to establish BIGCS as a research 
platform. More information is provided on our website (http://www.bigcs.com.cn/). 
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Figure legends 
Figure 1 Geographical location of the BIGCS eligible study area in southern China and site of the two campuses 
of the Guangzhou Women and Children’s Medical Centre 
Figure 2 Flow chart of cohort participant recruitment and follow-up by 30 April, 2016 
Figure 1 Click here to download Figure Figure 1.jpg 
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Table 1 Comparison of characteristics among women who agreed and disagreed to participate in BIGCS. 
Characteristics Agreed Disagreed P value * 
N 17214 5355  
Age (years), mean (SD) 29.2 (3.5) 29.0 (3.6) < 0.01 
Education level, n (%)    
High school or below 1720 (10.0) 807 (15.1) < 0.01 
Vocational/technical college 4253 (24.7) 1452 (27.1)  
Undergraduate 9132 (53.1) 2487 (46.4)  
Postgraduate 2109 (12.3) 609 (11.4)  
* Significant differences across groups were tested by using t test or Wilcoxon rank test. 
  
Tables Click here to download table Tables-revised.docx 
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Table 2 Comparison of characteristics among women who remained in the cohort and those who have 
withdrawn. 
Characteristics 
Remained  
in the cohort 
Consent 
withdrawn 
P value * 
N 16124 1090  
Age (years), mean (SD) 29.3 (3.5) 29.1 (3.8) 0.11 
Education level, n (%)    
High school or below 1508 (9.4) 188 (17.3) <0.01 
Vocational/technical college 3955 (24.5) 285 (26.2)  
Undergraduate 8620 (53.5) 502 (46.1)  
Postgraduate 2041 (12.7) 115 (10.6)  
Monthly income (Yuan), n (%)    
<1500 1543 (10.1) 103 (13.8) 0.04 
1500-4500 4367 (28.7) 211 (28.2)  
4501-9000 6503 (42.8) 304 (40.6)  
≥9001 2799 (18.4) 130 (17.4)  
Pre-pregnancy BMI (kg/m2), mean (SD)  20.4 (2.7) 20.1 (2.6) <0.01 
Parity, n (%)    
Primiparous 13189 (83.5) 720 (81.5) 0.01 
Multiparous 2599 (16.5) 164 (18.6)  
Delivery mode, n (%)    
Vaginal labor 8679 (63.7) 215 (60.7) 0.26 
Cesarean delivery 4953 (36.3) 139 (39.3)  
Preterm birth, n (%)    
No  13240 (94.0) 351 (92.1) 0.14 
Yes 853 (6.1) 30 (7.9)  
Infant gender, n (%)    
Male 7516 (52.5) 194 (51.2) 0.61 
Female 6795 (47.5) 185 (48.8)  
Birth weight(g), mean (SD) 3156 (458) 3159 (485) 0.88 
Low birth weight, n (%)    
No  13228 (93.3) 344 (92.5) 0.52 
Yes 947 (6.7) 28 (7.5)  
* Significant differences across groups were tested by using t test, Wilcoxon rank test or chi-square test. 
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Table 3 Data collection of mothers and their partners in BIGCS. 
Maternal data 
Antenatal (weeks)   Postnatal (months) 
<20 24-27 35-38 Delivery   6 weeks 6 12 36 Continue 
Mothers           
Demographics / Social 
 
  
       Date of birth √ 
  
       Ethnic group √ 
  
       Education √ 
  
       Marital status √ 
  
       Family members √ 
  
      
√ 
Housing, income √ 
  
      
√ 
Occupation / employment 
 
  
       Working status √ 
 
√ 
     
√ √ 
Working category, hours and posture √ 
 
√ 
      
√ 
Working environment √ 
 
√ 
      
√ 
Dwelling environment 
 
  
       Decoration √ 
  
      
√ 
Pets √ 
 
√ 
      
√ 
Mould √ 
 
√ 
      
√ 
Lampblack, insecticide, incense √ 
 
√ 
      
√ 
Lifestyle 
 
  
       Smoking status, passive smoking 
status 
√ 
 
√ 
  
√ 
   
√ 
Alcohol √ √ 
 
      
√ 
Beverage √ √ √ 
       Drinking water √ √ √ 
       Physical activity √ 
 
√ 
  
√ 
   
√ 
Health 
 
  
       Height √ 
  
       Weight √ √ √ √ 
 
√ √ √ √ √ 
Blood pressure 
 
√ √ 
  
√ √ √ √ √ 
Blood glucose 
 
  
  
√ √ √ √ √ 
Health status √ 
 
√ 
   
√ 
  
√ 
Menstrual cycle √ 
  
       Family medical history √ 
  
       Medical history √ 
  
       Medications √ 
 
√ 
  
√ √ √ √ 
 Vaginal bleeding during pregnancy √ 
 
√ 
       Micronutrient supplements √ 
 
√ 
  
√ 
   
√ 
Mental health √ 
 
√ 
  
√ √ √ √ √ 
Sleeping quality √ 
 
√ 
       Diet (food frequency questionnaire) 
 
√ 
 
  
√ 
    Biological samples 
 
  
       Blood 
 
√* √ 
       Faeces 
 
√ √ 
       Medical Records 
 
   
      Clinical test results 
   
√ 
      Ultrasound measurements 
   
√ 
      Pregnancy complications (e.g. GDM, PIH) 
 
√ 
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Medication 
   
√ 
      Delivery date, delivery mode 
 
  
√ 
          
Fathers           
Demographics / Social           
Date of birth √          
Ethnic group √          
Education √          
Housing, income √          
Health           
Height √          
Weight √          
Medical history √          
General health √          
Family medical history √          
Biological samples           
Blood  √         
* The first maternal blood sample was collected before 28 weeks of pregnancy. 
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Table 4 Data collection of children in BIGCS. 
Children's data 
Time points (months) 
At birth 6 weeks 6 12 36 Continue 
Gender √ √* 
    Date of birth  √ √* 
    Birth weight / length, apgar score √ √* 
    Physical measurements 
 
√ √ √ √ 
 Bregmatic fontanel 
 
√ √ √ 
  Hip joint examination 
 
√ 
    Dental eruption 
  
√ √ 
  Breast/testis volume 
    
√ 
 Diet 
      Breastfeeding 
 
√ √ √ √ 
 Milk or formula feeding 
 
√ √ √ √ 
 Food frequency/preference 
  
√ √ 
  Eating behavior/dietary restraint 
    
√ 
 Chinese herbal medicine 
 
√ √ √ √ 
 Water consumption 
 
√ √ √ 
  Micronutrient supplements 
 
√ √ √ √ 
 Family member, parenting practices 
 
√ √ √ √ 
 Sleeping 
 
√ √ √ √ 
 Dwelling environment 
      Lampblack, insecticide, incense 
 
√ √ √ √ √ 
Mould 
  
√ √ √ √ 
Router use 
 
√ √ √ √ √ 
Passive smoking status 
  
√ √ √ √ 
Pets 
  
√ √ √ √ 
Negative events 
      Illnesses ( fever, skin rash, wheeze& allergies) √ √ √ √ √ 
Medications 
 
√ √ √ √ 
 Immunization record 
 
√ √ √ 
  Neurobehavioral development 
 
√ √ √ √ 
 Language environment & learning languages    √ 
ASQ-III 
  
√ √ √ 
 Gesell 
   
√ 
  Medical Records 
      Clinical test results 
 
√ √ √ √ 
 Medication 
 
√ √ √ √ 
 Diagnosis 
 
√ √ √ √ √ 
Biological samples 
      Cord blood √   
Umbilical cord, placenta √      
Blood 
   
√ √ √ 
Faeces √  √ 
 
    √ 
* This information is collected for the women who do not deliver at Guangzhou Women and 
Children’s Medical Center.  
* 
  
Supplementary table 1
Click here to access/download
Supplementary material
Supplementary table 1.docx
  
COI form
Click here to access/download
Supplementary material
COI form.pdf
